Henry Sze

2.3k total citations · 2 hit papers
30 papers, 1.5k citations indexed

About

Henry Sze is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henry Sze has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Otorhinolaryngology, 17 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henry Sze's work include Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (10 papers) and Advanced Radiotherapy Techniques (5 papers). Henry Sze is often cited by papers focused on Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (10 papers) and Advanced Radiotherapy Techniques (5 papers). Henry Sze collaborates with scholars based in China, Hong Kong and United States. Henry Sze's co-authors include Anne W.M. Lee, Wai Tong Ng, Connie Chan, Lucy Chan, Oscar S.H. Chan, Amy Chang, Wai Man Hung, Rebecca M.W. Yeung, TH Lam and Yap‐Hang Chan and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Henry Sze

30 papers receiving 1.5k citations

Hit Papers

Evolution of treatment for nasopharyngeal cancer – Succes... 2014 2026 2018 2022 2014 2015 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Sze China 19 1.0k 621 560 533 252 30 1.5k
Meng‐Zhong Liu China 22 597 0.6× 785 1.3× 495 0.9× 723 1.4× 223 0.9× 51 1.7k
Tai-Xiang Lu China 24 1.6k 1.6× 1.1k 1.7× 743 1.3× 701 1.3× 177 0.7× 38 1.9k
Mengzhong Liu China 22 674 0.7× 896 1.4× 749 1.3× 803 1.5× 335 1.3× 77 1.9k
Roger K.C. Ngan China 16 969 1.0× 739 1.2× 671 1.2× 503 0.9× 171 0.7× 39 1.5k
Tomasz Rutkowski Poland 17 419 0.4× 247 0.4× 260 0.5× 358 0.7× 247 1.0× 102 981
Rou Jiang China 17 541 0.5× 398 0.6× 480 0.9× 288 0.5× 193 0.8× 22 987
C.F. Hess Germany 17 254 0.3× 449 0.7× 417 0.7× 361 0.7× 131 0.5× 50 1.2k
Song Qu China 19 419 0.4× 262 0.4× 480 0.9× 264 0.5× 200 0.8× 97 1.1k
Jay P. Reddy United States 18 223 0.2× 253 0.4× 356 0.6× 322 0.6× 239 0.9× 94 1.1k
Tyler P. Robin United States 17 169 0.2× 272 0.4× 608 1.1× 405 0.8× 198 0.8× 55 1.3k

Countries citing papers authored by Henry Sze

Since Specialization
Citations

This map shows the geographic impact of Henry Sze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Sze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Sze more than expected).

Fields of papers citing papers by Henry Sze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Sze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Sze. The network helps show where Henry Sze may publish in the future.

Co-authorship network of co-authors of Henry Sze

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Sze. A scholar is included among the top collaborators of Henry Sze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Sze. Henry Sze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soares, Andrey, María T. Bourlon, Alvin Wong, et al.. (2024). Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion. Clinical Genitourinary Cancer. 22(2). 467–475. 8 indexed citations
2.
Poon, Darren M.C., Kuen Chan, Tim Chan, et al.. (2022). Ethnic Pharmacogenomic Differences in the Management of Asian Patients with Metastatic Prostate Cancer. Cancers. 14(2). 407–407. 6 indexed citations
3.
Ng, Wai Tong, Stewart Y. Tung, Victor Lee, et al.. (2018). Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma—Exploration for Achieving Optimal 10-Year Therapeutic Ratio. International Journal of Radiation Oncology*Biology*Physics. 101(5). 1078–1086. 20 indexed citations
5.
Au, Kwok‐Hung, Roger K.C. Ngan, Alice Ng, et al.. (2017). Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study). Oral Oncology. 77. 16–21. 210 indexed citations
6.
Ng, Wai Tong, Roger K.C. Ngan, Dora L.�W. Kwong, et al.. (2017). Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 100(3). 630–638. 29 indexed citations
7.
Poon, Darren M.C., et al.. (2016). Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience. BMC Urology. 16(1). 12–12. 44 indexed citations
8.
Lam, Ka-On, Anne W.M. Lee, Cheuk‐Wai Choi, et al.. (2015). Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome With Access to Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 94(5). 1106–1112. 23 indexed citations
9.
Ng, Wai Tong, et al.. (2015). Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant. Current Treatment Options in Oncology. 16(9). 44–44. 14 indexed citations
10.
Sze, Henry, Pierre Blanchard, Wai Tong Ng, Jean‐Pierre Pignon, & Anne W.M. Lee. (2015). Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies. Hematology/Oncology Clinics of North America. 29(6). 1107–1122. 32 indexed citations
11.
Lee, Anne W.M., Wai Tong Ng, Lucy Chan, et al.. (2014). Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era. Radiotherapy and Oncology. 110(3). 377–384. 276 indexed citations breakdown →
12.
Sze, Henry, Lucy Chan, Wai Tong Ng, et al.. (2014). Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?. Oral Oncology. 50(12). 1188–1195. 26 indexed citations
13.
Kam, Michael, Frank Chi Sing Wong, Dora L.�W. Kwong, Henry Sze, & Anne W.M. Lee. (2013). Current controversies in radiotherapy for nasopharyngeal carcinoma (NPC). Oral Oncology. 50(10). 907–912. 15 indexed citations
14.
Lee, Anne W.M., Wai Tong Ng, L.K. Chan, et al.. (2012). The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement. Oral Oncology. 48(10). 1007–1013. 97 indexed citations
16.
Lee, Anne W.M., Wai Tong Ng, Yap‐Hang Chan, et al.. (2012). The battle against nasopharyngeal cancer. Radiotherapy and Oncology. 104(3). 272–278. 182 indexed citations
17.
Sze, Henry, et al.. (2011). Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: The importance of co-morbidity assessment. Oral Oncology. 48(2). 162–167. 36 indexed citations
18.
Sze, Henry, et al.. (2011). RapidArc radiotherapy planning for prostate cancer: Single-arc and double-arc techniques vs. intensity-modulated radiotherapy. Medical dosimetry. 37(1). 87–91. 41 indexed citations
19.
Sze, Henry, et al.. (2009). Fibromatosis of the neck causing airway obstruction managed effectively with weekly low-dose methotrexate and vinblastine.. PubMed. 15(3). 221–3. 8 indexed citations
20.
Yau, Tsz‐Kok, Inda Soong, Henry Sze, et al.. (2008). Trends and Patterns of Breast Conservation Treatment in Hong Kong: 1994–2007. International Journal of Radiation Oncology*Biology*Physics. 74(1). 98–103. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026